Safety issues in selected patients implanted with Boston Scientific EMBLEM subcutaneous cardioverter defibrillator systems
Kardiol Pol
.
2021 Feb 25;79(2):223-224.
doi: 10.33963/KP.15833.
Epub 2021 Feb 25.
Authors
Maciej Kempa
1
,
Maciej Sterliński
2
,
Przemysław Mitkowski
3
,
Adam Sokal
4
,
Krzysztof Kaczmarek
5
,
Jarosław Kaźmierczak
6
,
Andrzej Przybylski
7
8
Affiliations
1
Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdańsk, Poland
2
1st Arrhythmia Department, National Institute of Cardiology, State Scientific Institute, Warsaw, Poland
3
1st Department of Cardiology, Chair of Cardiology, Karol Marcinkowski University of Medical Sciences, Poznań, Poland
4
1st Department of Cardiology and Angiology, Silesian Centre of Heart Diseases, Zabrze, Poland
5
Department of Electrocardiology, Medical University of Lodz, Łódź, Poland
6
Department of Cardiology, Pomeranian Medical University, Szczecin, Poland
7
Medical College, University of Rzeszow, Rzeszów, Poland;
8
Cardiology Department with the Acute Coronary Syndromes Subdivision, Clinical Provincial Hospital No 2, Rzeszów, Poland
PMID:
33635036
DOI:
10.33963/KP.15833
No abstract available
Publication types
Letter
MeSH terms
Defibrillators, Implantable* / adverse effects
Electric Countershock
Electrocardiography
Humans